Latest healthcare news
COVID-19 Therapies in the Community Setting
The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback's interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
Tau Protein and Neurodegenerative Diseases
An article published by Stahlberg and Riek in Nature September 2021 establishes that high resolution structures of previously uncharacterised strains of tau fibril purified from the postmortem brains of individuals with various neurodegenerative diseases could be used...
What Side Effects are Possible Following SARS-Cov-2 Vaccination Booster?
A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose. The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...
Remote Working, Is It Beneficial?
An interesting paper published on 9th September 2021, in Nature Human Behaviour by Yang and others looked at the effect of remote working on collaboration amongst information workers. The COVID-19 pandemic caused a rapid shift to full time remote work for...
Can Non-Invasive Wrist Worn Wearable Devices Detect Acute Viral Respiratory Infection and Predict the Severity of Outcome Before Symptom Onset?
An interesting article published by Grzesiak and others in the Journal of the American Medical Association network open on September 29th 2021 looked at this issue. Currently, there exist no pre-symptomatic screening methods to identify individuals infected with...
Why are Extremely Premature Infants at High Risk from Brain Damage?
An interesting paper by Seki and others published in Cell Host and Microbe September 2021 tries to explain this issue. Premature infants are at a substantial risk of suffering from perinatal white matter injury. Although the gut microbiota has been...
The Rapid COVID-19 Vaccine Rollout: Immense Success but Challenges Ahead!
An interesting comment by Sandmann published on September 22nd 2021 in Lancet Infectious Diseases considers the vaccination rollout in Israel. In The Lancet Infectious Diseases, Eric Haas and colleagues estimated the benefits of the rapid mass roll-out of the Pfizer...
A New Strategy for Health and Sustainable Development in the Light of the COVID-19 Pandemic.
A comment article published by Monti and others in The Lancet September 19th argues that to build a post-pandemic future, in which everyone's health is protected and promoted, we must learn from the events of the COVID-19 pandemic and previous crises. The Pan-European...
COVID-19 Screening, Test Sensitivity or Test Frequency and Turnaround Times?
An interesting article in Science Advances published by Larremore and others in January 2021 looks at this important subject. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and...
How Can We Determine Who is at Risk from COVID-19 Vaccination?
A helpful research study published by Hippisley-Cox and others in the BMJ 17th September 2021 helps to analyse this. They identified a range of important clinical risk factors for severe COVID-19 outcomes in people in the UK, 14 days or more after COVID-19 vaccination...
